A randomized trial of laparoscopic versus open surgery for rectal cancer.

BACKGROUND Laparoscopic resection of colorectal cancer is widely used. However, robust evidence to conclude that laparoscopic surgery and open surgery have similar outcomes in rectal cancer is lacking. A trial was designed to compare 3-year rates of cancer recurrence in the pelvic or perineal area (locoregional recurrence) and survival after laparoscopic and open resection of rectal cancer. METHODS In this international trial conducted in 30 hospitals, we randomly assigned patients with a solitary adenocarcinoma of the rectum within 15 cm of the anal verge, not invading adjacent tissues, and without distant metastases to undergo either laparoscopic or open surgery in a 2:1 ratio. The primary end point was locoregional recurrence 3 years after the index surgery. Secondary end points included disease-free and overall survival. RESULTS A total of 1044 patients were included (699 in the laparoscopic-surgery group and 345 in the open-surgery group). At 3 years, the locoregional recurrence rate was 5.0% in the two groups (difference, 0 percentage points; 90% confidence interval [CI], -2.6 to 2.6). Disease-free survival rates were 74.8% in the laparoscopic-surgery group and 70.8% in the open-surgery group (difference, 4.0 percentage points; 95% CI, -1.9 to 9.9). Overall survival rates were 86.7% in the laparoscopic-surgery group and 83.6% in the open-surgery group (difference, 3.1 percentage points; 95% CI, -1.6 to 7.8). CONCLUSIONS Laparoscopic surgery in patients with rectal cancer was associated with rates of locoregional recurrence and disease-free and overall survival similar to those for open surgery. (Funded by Ethicon Endo-Surgery Europe and others; COLOR II ClinicalTrials.gov number, NCT00297791.).

[1]  Rieken,et al.  [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer]. , 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[2]  Jacques Ferlay,et al.  GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 , 2013 .

[3]  J. Milsom,et al.  Long-Term Outcomes of Patients Undergoing Curative Laparoscopic Surgery for Mid and Low Rectal Cancer , 2009, Diseases of the colon and rectum.

[4]  R. Veldkamp,et al.  Laparoscopic surgery versus open surgery for colon cancer : short-term outcomes of a randomised trial , 2022 .

[5]  T. Häggmark,et al.  Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer , 2007, The British journal of surgery.

[6]  G. Slaney.  Results of treatment of carcinoma of the colon and rectum. , 1971, Modern trends in surgery.

[7]  G. Schiechl,et al.  RORγt+ hematopoietic cells are necessary for tumor cell proliferation during colitis‐associated tumorigenesis in mice , 2015, European journal of immunology.

[8]  A. Darzi,et al.  Systematic Review of Learning Curves for Minimally Invasive Abdominal Surgery: A Review of the Methodology of Data Collection, Depiction of Outcomes, and Statistical Analysis , 2014, Annals of surgery.

[9]  J. Coffey,et al.  A Randomized Trial of Laparoscopic versus Open Surgery for Rectal Cancer. , 2015, The New England journal of medicine.

[10]  I. Nagtegaal,et al.  Circumferential Margin Involvement Is Still an Important Predictor of Local Recurrence in Rectal Carcinoma: Not One Millimeter but Two Millimeters Is the Limit , 2002, The American journal of surgical pathology.

[11]  P. Quirke,et al.  The Modern Abdominoperineal Excision: The Next Challenge After Total Mesorectal Excision , 2005, Annals of surgery.

[12]  I. Sayek,et al.  Laparoscopic surgery is associated with less tumour growth stimulation than conventional surgery: An experimental study , 1997, The British journal of surgery.

[13]  Laurent Beaugerie,et al.  Cancers complicating inflammatory bowel disease. , 2015, The New England journal of medicine.

[14]  S. Itzkowitz,et al.  Intestinal inflammation and cancer. , 2011, Gastroenterology.

[15]  G. Noël,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer , 2002 .

[16]  T. Macdonald,et al.  Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth , 2014, Oncogene.

[17]  M. Cuesta,et al.  Surgical Stress Response and Postoperative Immune Function After Laparoscopy or Open Surgery With Fast Track or Standard Perioperative Care: A Randomized Trial , 2012, Annals of surgery.

[18]  V. Lemmens,et al.  The Dutch surgical colorectal audit. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  R. Aitken,et al.  Mesorectal excision for rectal cancer , 1996, The British journal of surgery.

[20]  F. Pallone,et al.  Th17 Cytokines in Inflammatory Bowel Diseases: Discerning the Good from the Bad , 2013, International reviews of immunology.

[21]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[22]  F. Leblanc,et al.  Laparoscopic Versus Open Surgery for Rectal Cancer: Long-Term Oncologic Results , 2009, Annals of surgery.

[23]  M. Neurath,et al.  Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer , 2015, Gut.

[24]  W. Hop,et al.  Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. , 2013, The Lancet. Oncology.

[25]  Antoni Castells,et al.  Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial , 2002, The Lancet.

[26]  A. Schwartzman,et al.  Abdominal wall recurrence after laparoscopic colectomy for colon cancer. , 1994, Surgery.

[27]  J. Park,et al.  Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. , 2010, The Lancet. Oncology.

[28]  Philip Quirke,et al.  Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial , 2005, The Lancet.

[29]  Laurence Collette,et al.  Chemotherapy with preoperative radiotherapy in rectal cancer. , 2006, The New England journal of medicine.

[30]  L. Collette,et al.  Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. , 2014, The Lancet. Oncology.

[31]  Mario Morino,et al.  Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. , 2009, The Lancet. Oncology.

[32]  J. Park,et al.  Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. , 2014, The Lancet. Oncology.

[33]  G. Kazemier,et al.  Subcutaneous metastases after laparoscopic colectomy , 1994, The Lancet.

[34]  R. Heald,et al.  RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCER , 1986, The Lancet.

[35]  D. Jayne,et al.  Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.